These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 11408504
1. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study. Hawkins DS, Anderson JR, Paidas CN, Wharam MD, Qualman SJ, Pappo AS, Scott Baker K, Crist WM. J Clin Oncol; 2001 Jun 15; 19(12):3073-9. PubMed ID: 11408504 [Abstract] [Full Text] [Related]
2. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. J Clin Oncol; 2001 Jun 15; 19(12):3091-102. PubMed ID: 11408506 [Abstract] [Full Text] [Related]
3. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. Meza JL, Anderson J, Pappo AS, Meyer WH, Children's Oncology Group. J Clin Oncol; 2006 Aug 20; 24(24):3844-51. PubMed ID: 16921036 [Abstract] [Full Text] [Related]
4. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. Baker KS, Anderson JR, Link MP, Grier HE, Qualman SJ, Maurer HM, Breneman JC, Wiener ES, Crist WM. J Clin Oncol; 2000 Jun 20; 18(12):2427-34. PubMed ID: 10856103 [Abstract] [Full Text] [Related]
6. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN, Crist WM. J Clin Oncol; 2003 Jan 01; 21(1):78-84. PubMed ID: 12506174 [Abstract] [Full Text] [Related]
7. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Michalski JM, Meza J, Breneman JC, Wolden SL, Laurie F, Jodoin M, Raney B, Wharam MD, Donaldson SS. Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1027-38. PubMed ID: 15234036 [Abstract] [Full Text] [Related]
8. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children]. Xu N, Duan C, Jin M, Zhang DW, Su Y, Yu T, He LJ, Fu LB, Zeng Q, Wang HM, Zhang WP, Ni X, Ma XL. Zhonghua Er Ke Za Zhi; 2019 Oct 02; 57(10):767-773. PubMed ID: 31594063 [Abstract] [Full Text] [Related]
12. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group. Hayes-Jordan A, Stoner JA, Anderson JR, Rodeberg D, Weiner G, Meyer WH, Hawkins DS, Arndt CA, Paidas C, Children's Oncology Group. J Pediatr Surg; 2008 May 02; 43(5):831-6. PubMed ID: 18485948 [Abstract] [Full Text] [Related]
13. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Joshi D, Anderson JR, Paidas C, Breneman J, Parham DM, Crist W, Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer; 2004 Jan 02; 42(1):64-73. PubMed ID: 14752797 [Abstract] [Full Text] [Related]
14. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. Donaldson SS, Meza J, Breneman JC, Crist WM, Laurie F, Qualman SJ, Wharam M, Children's Oncology Group Soft Tissue Sarcoma Committee (formely Intergroup Rhabdomyosarcoma Group) representing the Children's Oncology Group and the Quality Assurance Review Center. Int J Radiat Oncol Biol Phys; 2001 Nov 01; 51(3):718-28. PubMed ID: 11597814 [Abstract] [Full Text] [Related]
15. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. Crist WM, Garnsey L, Beltangady MS, Gehan E, Ruymann F, Webber B, Hays DM, Wharam M, Maurer HM. J Clin Oncol; 1990 Mar 01; 8(3):443-52. PubMed ID: 2407808 [Abstract] [Full Text] [Related]
19. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). Neville HL, Andrassy RJ, Lobe TE, Bagwell CE, Anderson JR, Womer RB, Crist WM, Wiener ES. J Pediatr Surg; 2000 Feb 01; 35(2):317-21. PubMed ID: 10693687 [Abstract] [Full Text] [Related]
20. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. Rodeberg D, Arndt C, Breneman J, Lyden E, Donaldson S, Paidas C, Andrassy R, Meyer W, Wiener E. J Pediatr Surg; 2005 Jan 01; 40(1):256-62. PubMed ID: 15868594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]